decoration

Poids de l’Open access dans la production CNRS

Titre
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study
BSO - Titre
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study
DOI
DOAI
Identifiant WoS
WOS:000408273800023
Accès ouvert
OA - Non
Source - Accès ouvert
OA - Non
Type d'accès
Non OA
Editeur

Elsevier

Source

EUROPEAN JOURNAL OF CANCER

ISSN
0959-8049
Type de document
  • Article
Notoriété
4 - Excellente
CNRS
Oui
CNRS - Institut
  • INSB - Institut des sciences biologiques
uid:/WQN9M1BC
Powered by Lodex 9.6.0
decoration